Keyphrases
Escherichia Coli
73%
Yersiniabactin
56%
Siderophore
55%
Uropathogenic Escherichia Coli
54%
COVID-19
53%
Convalescent Plasma
46%
Virulence
40%
Urinary Tract Infection
39%
Myeloperoxidase
35%
Hydrogen Peroxide
22%
Metallophore
22%
Phagocytes
21%
Mass Spectrometry
19%
Urologic Chronic Pelvic Pain Syndrome
19%
Enterobactin
19%
Eosinophil Peroxidase
18%
Bacteriuria
18%
Yersinia
18%
Convalescent Plasma Therapy
17%
Pathogenicity Island
16%
Siderocalin
16%
Uropathogens
15%
Heme
15%
Enterobacteria
14%
Metabolomics
14%
Bacterial Pathogens
13%
Deoxycytidine
13%
Hospitalized Patients
12%
High Titer
12%
Urinary Tract
12%
Interstitial Cystitis
11%
Plasmodium Falciparum
11%
Bloodstream Infection
11%
Eosinophils
11%
Antimicrobial
11%
Inflammation
11%
Nucleobases
10%
Virulence Factors
10%
Malaria Parasite
10%
5-Bromouracil
10%
Asymptomatic Bacteriuria
10%
Bladder Pain Syndrome
10%
Immunosuppression
9%
Clostridium Difficile Infection
9%
Serological Assay
9%
Neutralizing Antibodies
9%
Ortho
9%
Catheter-associated Urinary Tract Infection (CAUTI)
9%
Antibacterial Activity
9%
FimH
9%
Immunology and Microbiology
Escherichia coli
100%
Urinary Tract
56%
Uropathogenic Escherichia Coli
53%
Infectious Agent
53%
Metabolome
25%
COVID-19
23%
Blood Plasma
21%
Pathogenicity Island
17%
Yersinia
17%
Eosinophil
14%
Biofilm
14%
Enterobacteriaceae
14%
Peroxidase
14%
Virulence Factor
12%
Neutrophil
12%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Microbiome
11%
Titer
11%
Pathogenic Escherichia Coli
9%
Myeloperoxidase
9%
Neutralizing Antibody
9%
Heme
9%
Secondary Metabolite
9%
Microorganism
8%
Pathogenic Potential
7%
Metabolite
7%
Outer Membrane
7%
Staphylococcus Aureus
7%
Phagocyte
7%
Lineages
6%
Precursor
6%
Immunity
6%
Lipocalin
6%
Lipocalin-2
6%
Plasmodium
6%
Bacterial Growth
5%
Plasmodium falciparum
5%
Liquid Chromatography Mass Spectrometry
5%
Halogenation
5%
Hydrogen Peroxide
5%